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The skin and mucous membranes of healthy subjects are colonized by strains of Staphylococcus epidermidis showing a high
diversity of genomic DNA polymorphisms. Prolonged hospitalization and the use of invasive procedures promote changes in the
microbiota with subsequent colonization by hospital strains. We report here a patient with prolonged hospitalization due to
chronic pancreatitis who was treated with multiple antibiotics, invasive procedures and abdominal surgery. We studied the
dynamics of skin colonization by S. epidermidis leading to the development of catheter-related infections and compared the
genotypic profile of clinical and microbiota strains by pulsed field gel electrophoresis. During hospitalization, the normal S.
epidermidis skin microbiota exhibiting a polymorphic genomic DNA profile was replaced with a hospital-acquired biofilm-
producer S. epidermidis strain that subsequently caused repetitive catheter-related infections.
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Staphylococcus epidermidis colonizes the skin and
mucous membranes and represents the main bacterium in
the normal human microbiota (1). Over the last 20 years, S.
epidermidis has been increasingly reported to be the caus-
ative agent of hospital infections, mainly associated with
prosthetic devices such as central venous catheters (CVC)
(2).
The pathogenesis of CVC colonization by S. epidermi-
dis sequentially includes adhesion, persistence and later
dissemination of S. epidermidis to the bloodstream (3).
Biofilm formation is the main virulent factor resulting from
the biosynthesis of polysaccharide intercellular adhesion,
promoting cellular aggregation, biofilm accumulation (4-6)
and offering a protective shield against the immune system
and against antibiotic therapy (7).
The skin and mucous membranes of healthy subjects
are colonized by strains of S. epidermidis showing a high
diversity of genomic DNA polymorphisms. Prolonged hos-
pitalization and the use of invasive procedures promote
changes in the microbiota with subsequent colonization by
hospital strains that might express virulent factors such as
biofilm.
This report illustrates the importance of prolonged hos-
pitalization, invasive procedures and exposure to multiple
antibiotics in the change of the normal S. epidermidis skin/
mucous microbiota to a highly adaptable hospital strain
responsible for the development of catheter-related infec-
tions.
A 45-year-old male was hospitalized on October 21,
2001 at the University Hospital of UNICAMP, Brazil, due to
chronic pancreatitis and pancreatic pseudocyst. On the
4th day of hospitalization (D4), parenteral nutrition was
started through a peripheral vein and continued for 4 days.
On D8, a CVC was inserted into the right subclavial vein.
On D16, the patient presented fever and nocturnal sweat-
ing and the CVC was removed.
Brazilian Journal of Medical and Biological Research (2009) 42: 294-298
ISSN 0100-879X Short Communication
295
Braz J Med Biol Res 42(3) 2009
 Hospital strain colonization by Staphylococcus epidermidis
www.bjournal.com.br
The catheter tip was cultured and two blood samples
were collected simultaneously for culture. The microbio-
logical study of the catheter tip, according to Maki’s semi-
quantitative technique (8), and the blood cultures yielded
positive results for S. epidermidis susceptible to multiple
antibiotics, except penicillin-G (Table 1; D16). At that time,
the microbiota of the patient’s palms, axillae, site of CVC
insertion, and nasal mucous membrane were rigorously
examined for the presence of S. epidermidis. The S. epi-
dermidis strains isolated from the skin/mucous microbiota
and from the catheter tip were genotyped using pulsed
field gel electrophoresis (9) and tested for biofilm produc-
tion by the Congo red agar technique (10).
The automated Vitek® 2 system (BioMérieux Vitek,
Inc., USA) was used to identify all strains and to test their
antibiotic susceptibility. The genotyping of the microbiota
strains revealed S. epidermidis with polyclonal profiles
susceptible to multiple antibiotics (Figure 1, lanes 2 to 6).
The comparison of the DNA genomic profiles of S. epider-
midis isolated from the CVC tip (Figure 1, lane 2) with
microbiota strains (Figure 1, lanes 3 to 6) confirmed that
the genomic profiles were not related.
On D25, parenteral nutrition was initiated via a CVC
inserted into the left jugular vein. On D33, the patient
presented fever and inflammatory signs at the site of
catheter implantation and ceftazidime was started on D35.
The CVC was removed on D37 and inserted into the right
jugular vein, and parenteral nutrition was continued. The
catheter tip was cultured and blood cultures were per-
formed. The microbiological results revealed positive blood
Figure 1. Genomic DNA profiles of Staphylococcus
epidermidis strains obtained using SmaI restriction
endonuclease enzyme followed by pulsed field gel
electrophoresis. Lanes 1 and 15, lambda ladder
marker; D16: lane 2, isolate from catheter tip; lanes 3
to 6, microbiota; D37: lane 7, isolate from catheter tip;
lanes 8 to 10, representative microbiota strains of
predominant (16/18) profile A; D54: lane 11, catheter
tip; lanes 12 and 13, representative microbiota strains
of predominant (8/9) profile A; D66: lane 14, isolate
from catheter tip. D16, D37, D54, and D66 indicate
the days when the specimens were obtained.
Table 1. Minimum inhibitory concentration (MIC) to antimicrobial drugs of Staphylococcus epidermidis strains isolated from central
vascular catheter tips during the patient’s hospitalization.
CIP CLI ERY GEN OXA PEN RIF TET SXT VAN
Reference values
Susceptible ≤1 ≤0.5 ≤0.5 ≤4 ≤0.25 ≤0.12 ≤1 ≤4 ≤2/38 ≤4
Intermediate 2 1-2 1-4 8 - - 2 8 - 8-16
Resistant ≥4 ≥4 ≥8 ≥16 ≥0.5 ≥0.25 ≥4 ≥16 ≥8/152 ≥32
Day of hospitalization
D16 0.5 0.5 0.5 2 2 16 1 1 10 2
D37 4 0.5 0.5 2 8 16 1 1 160 2
D54 4 0.5 0.5 16 8 16 1 1 160 2
D66 4 0.5 0.5 16 8 16 1 1 160 2
D97 4 0.5 0.5 16 8 16 1 1 160 2
Data are reported as MIC values in μg/mL. CIP = ciprofloxacin; CLI = clindamycin; ERY = erythromycin; GEN = gentamicin; OXA =
oxacillin; PEN = penicillin-G; RIF = rifampin; TET = tetracycline; SXT = trimethoprim/sulfamethoxazole; VAN = vancomycin.
Reference values according to the NCCLS M100-S12 (M7) (20).
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cultures for Enterobacter cloacae, and S. epidermidis was
isolated from the CVC tip. At that time, a new S. epidermi-
dis microbiota investigation was carried out, when 18
different S. epidermidis strains were collected. Genotyping
revealed S. epidermidis strains with an oligoclonal profile,
16 of which were identical to the strain from the catheter tip
(profile A) while two other strains had profile O1. Profile A
produced biofilm and was resistant to multiple antibiotics,
including oxacillin (Figure 1, lanes 8 to 10). The strain
isolated from the catheter tip was genotypically and phe-
notypically identical to the microbiota strains (Figure 1,
lane 6).
The patient had persistent fever until D54 when an-
other blood culture was collected. The CVC was removed,
the catheter tip was cultured and imipenem was adminis-
tered for two consecutive days. However, it should be
pointed out that ciprofloxacin had already been given for
four consecutive days since D51. Blood cultures were
positive for E. cloacae and the catheter tip was positive for
a biofilm-producing and resistant strain of S. epidermidis.
A new CVC was inserted into the left jugular vein, and
cefepime was added to the therapy and administered until
D67. Another thorough search was performed in the
patient’s microbiota, and S. epidermidis was isolated in
nine cultures from different sites, including the insertion
area of the CVC. The predominant microbiota strain (8/9)
and catheter tip S. epidermidis strains had identical ge-
nomic DNA profile A. On D66, the CVC was removed for
technical reasons and the tip was cultured and resulted
positive for S. epidermidis genotypically identical to the
strains from previous episodes (D37 and D54; Figure 1,
lane 13). On D71, the patient received ceftazidime and
underwent surgical enucleation of the pancreas head and
a pancreato-jejunal shunt. After surgery, the patient re-
ceived levofloxacin. On D77, the patient had septic shock
and the peritoneal fluid and surgical incision cultures were
positive for Pseudomonas aeruginosa and E. cloacae.
Vancomycin and imipenem were introduced. On D79,
resuturing of the enteric-enteric anastomosis and laparo-
scopic trans-anastomotic jejunostomy were performed.
The administration of vancomycin and imipenem was con-
tinued for 21 days. On D97, a new episode of S. epidermi-
dis CVC infection was observed; however, for technical
reasons, genotyping analysis was not performed. No new
episodes of CVC infection were observed up to D145,
when the patient was discharged.
Studies conducted on the dynamics of epidermal colo-
nization by S. epidermidis prior to CVC-related infection
have suggested that changes from a polyclonal, multiple
antibiotic susceptible microbiota to an oligoclonal profile
precede bloodstream infections caused by S. epidermidis
in hospitalized patients (11). In the present patient, the
replacement of the normal skin/mucous microbiota with a
hospital-acquired resistant strain of S. epidermidis was
well documented by molecular typing.
The use of broad-spectrum antibiotics is the most
important factor causing selective pressure on the normal
microbiota. The present patient was on prolonged and
multiple antibiotic therapy throughout the hospitalization
period. Some antibiotics, such as ciprofloxacin, are ex-
creted by the sudoriparous glands and may alter the skin
microbiota, including S. epidermidis strains (12).
S. epidermidis strains isolated on the 16th day of
hospitalization were susceptible to the tested antibiotic
(Table 1), did not produce biofilm and had polymorphic
genotype profiles. At that time, the patient had not received
an antibiotic. A different profile was observed in the second
episode: most of the microbiota strains collected on day 37
were genotypically identical and coincident with CVC
strains, producing biofilm and exhibiting a profile of multi-
resistance to antibiotics, although the antibiotic therapy
was not specifically directed at S. epidermidis, but at E.
cloacae, which was simultaneously isolated from the blood
culture.
Although in that episode the catheter tip had more than
15 colonies, the clinical team considered that S. epidermi-
dis worked as a colonizing microorganism rather than as
an infectious agent. This shows some differences in the
management of infection by the clinical team and in the
criteria used by the Nosocomial Infection Committee for
surveillance. This finding reflects the difficulty in defining
the presence of S. epidermidis as colonization or infection,
mainly when a second potential pathogen is present.
Although a patient’s skin microbiota is frequently re-
garded as the main source of infection, the investigation of
outbreaks associated with S. epidermidis has detected the
presence of endemic strains within medical centers (13).
During a period of 7 months we analyzed the genotypic
profile of S. epidermidis of skin microbiota and clinical
blood samples and/or CVC infection of several patients
and the predominant genotypic profile, denominated A,
was observed in 31.2% (77/247) of the strains analyzed
(Blum-Menezes D, Bratfich OJ, Moretti ML, unpublished
data). The present patient was part of this surveillance
study.
The selective pressure of antibiotics on S. epidermidis
from normal microbiota might have caused in our patient
the colonization of skin/mucous membrane with a pre-
dominant hospital-acquired S. epidermidis strain, demon-
strating a more resistant antibiotic profile. This biofilm-
producing strain was well adapted to our hospital condi-
tions, and was found to colonize and cause bloodstream
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infections in other patients in our hospital, as cited above.
Biofilm-producing bacteria are highly resistant to anti-
biotics due to the biofilm environment, which represents a
mechanical barrier against antibiotics. The expression of
resistance mechanisms in biofilm-producing bacteria can
be due to the “special lifestyle” present inside the biofilm,
which is highly resistant to host defenses and to antibiotics
(14). It is interesting to emphasize that, although the sus-
ceptibility to in vitro glycopeptides and to other antibiotic
classes was demonstrated, the same clone colonized the
patient for long periods of time. The discrepancy between
in vivo biofilm-producing strains and therapeutic failure in
the presence of an apparently favorable in vitro suscepti-
bility, analyzed in planktonic conditions, has been dis-
cussed (15).
The presence of prosthetic devices, such as a CVC in
our patient, represented an important risk factor for the
development of CVC-related bloodstream infections (16).
The multiple insertions of CVCs in our patient broke the
integrity of the skin, therefore promoting the invasion of the
endemic multiresistant biofilm-producing S. epidermidis,
which colonized the skin/mucous membrane. Our patient
also presented a systemic infection caused by E. cloacae
at the same time. Recently, some reports have demon-
strated an association between S. epidermidis bloodstream
infection and other microorganisms (17,18). The produc-
tion of biofilm increases the resistance to antibiotics (19)
and promotes a symbiotic relation among different micro-
organisms (18). In the present case, the constant pres-
ence of a biofilm-producing S. epidermidis may have cre-
ated a favorable environment for the colonization and
infection by other typical nosocomial microorganisms such
as E. cloacae and P. aeruginosa. Therefore, we empha-
size the importance of biofilm-producing strains as a reser-
voir for other typical pathogens, considering the recur-
rence of episodes of colonization by S. epidermidis and E.
cloacae.
The present report clearly demonstrated the hospital
acquisition of an endemic resistant strain of S. epidermidis
and the subsequent steps of skin colonization directly
related to repetitive CVC infections by the same strain.
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